FDA Inspection
Nanjing Xingyin Pharmaceutical Group Co. Ltd.Nanjing Xingyin Pharmaceutical Group Co. Ltd. – FDA Inspection, Aug 31, 2017
Record Details
This FDA Inspection record concerns Nanjing Xingyin Pharmaceutical Group Co. Ltd., with an inspection on August 31, 2017, issued by the Center for Veterinary Medicine, covering veterinary.
- Inspection Date
- August 31, 2017
- Product Type
- Veterinary
- Person
- Meisha R. Sampson (Issuing Officer)
View Company Profile
ID · 148f570c-97e5-4b5b-a21a-b8bf7a8d9a79
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1024147
- FDA center
- Animal Drugs & Feeds
- Project area
- Pre-Approval Eval. of Animal Drugs and Food Additives
- Outcome
- Form 483 issued
Other FDA inspections of Nanjing Xingyin Pharmaceutical Group Co. Ltd.
2| Date | Classification | Office | Project area |
|---|---|---|---|
| January 19, 2024 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 9, 2018 | VAI | Center for Veterinary Medicine | Pre-Approval Eval. of Animal Drugs and Food Additives |
Other documents for Nanjing Xingyin Pharmaceutical Group Co. Ltd.
- FDA Inspection 1228230 - 2024-01-19
- FDA Inspection 1074969 - 2018-11-09
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.